These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 35811549

  • 21. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
    Kumar B, Khaleghzadegan S, Mears B, Hatano K, Kudrolli TA, Chowdhury WH, Yeater DB, Ewing CM, Luo J, Isaacs WB, Marchionni L, Lupold SE.
    Oncotarget; 2016 Nov 08; 7(45):72593-72607. PubMed ID: 27683042
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells.
    Huo C, Kuo YY, Lin CY, Shiah SG, Li CY, Huang SP, Chen JK, Wang WC, Kung HJ, Chuu CP.
    Cancer Med; 2024 Aug 08; 13(16):e70106. PubMed ID: 39149855
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-99b-5p downregulates protein synthesis in human primary myotubes.
    Zacharewicz E, Kalanon M, Murphy RM, Russell AP, Lamon S.
    Am J Physiol Cell Physiol; 2020 Aug 01; 319(2):C432-C440. PubMed ID: 32608991
    [Abstract] [Full Text] [Related]

  • 25. microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.
    Wang D, Lu G, Shao Y, Xu D.
    Biosci Rep; 2017 Apr 30; 37(2):. PubMed ID: 28188157
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. MicroRNA-495 Regulates Migration and Invasion in Prostate Cancer Cells Via Targeting Akt and mTOR Signaling.
    Li JZ, Wang ZL, Xu WH, Li Q, Gao L, Wang ZM.
    Cancer Invest; 2016 Apr 30; 34(4):181-8. PubMed ID: 27031291
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
    Natani S, Ramakrishna M, Nallavolu T, Ummanni R.
    Prostate; 2023 Jul 30; 83(10):936-949. PubMed ID: 37069746
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E, de la Cruz-Ojeda P, Contreras L, González R, Negrete M, Rodríguez-Hernández MA, Marín-Gómez LM, Álamo-Martínez JM, Calvo A, Gómez-Bravo MA, de la Cruz J, Padillo J, Muntané J.
    Cell Physiol Biochem; 2020 May 06; 54(3):457-473. PubMed ID: 32369692
    [Abstract] [Full Text] [Related]

  • 33. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
    Duan XM, Liu XN, Li YX, Cao YQ, Silayiding A, Zhang RK, Wang JP.
    Kaohsiung J Med Sci; 2019 Nov 06; 35(11):659-671. PubMed ID: 31332950
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways.
    Gu Z, You Z, Yang Y, Ding R, Wang M, Pu J, Chen J.
    Bioengineered; 2021 Dec 06; 12(1):4719-4735. PubMed ID: 34338146
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
    Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X, Zheng L, Xue Z, Xia W, Zhang B, Ding T, Cao Y, Tian Z, Shi Q, He X.
    BMC Cancer; 2012 Nov 23; 12():546. PubMed ID: 23173671
    [Abstract] [Full Text] [Related]

  • 37. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
    John Clotaire DZ, Zhang B, Wei N, Gao R, Zhao F, Wang Y, Lei M, Huang W.
    Biochem Biophys Res Commun; 2016 Mar 25; 472(1):194-200. PubMed ID: 26920049
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer.
    Liu J, Li J, Ma Y, Xu C, Wang Y, He Y.
    Bioengineered; 2021 Dec 25; 12(1):3240-3251. PubMed ID: 34238129
    [Abstract] [Full Text] [Related]

  • 40. miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.
    Gong AY, Eischeid AN, Xiao J, Zhao J, Chen D, Wang ZY, Young CY, Chen XM.
    BMC Cancer; 2012 Oct 24; 12():492. PubMed ID: 23095762
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.